SYmptom Study of radioThErapy in MeSothelioma

Recruiting

You are on the General Public view
  • Source

    -
    Public Title SYmptom Study of radioThErapy in MeSothelioma
    Acronym SYSTEMS
    Source of Record URL http://isrctn.org/ISRCTN10644347
  • Trial

    -
    Health Condition(s) or Problem Malignant pleural mesothelioma (MPM)
    Lay Summary http://cancerhelp.cancerresearchuk.org/trials/a-study-find-out-radiotherapy-help-control-pain-people-mesothelioma (from ISRCTN)
    Who can enter the trial 1. >/=18 years of age. 2. Histological or multi-disciplinary team (MDT) diagnosis of mesothelioma 3. Able to complete study assessments 3. Life expectancy of at least 3 months based on clinical judgement 4. Due to receive radiotherapy for pain resulting from mesothelioma (defined as index site ? site of radiotherapy) 5. Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 6. CT scan within 6 weeks of radiotherapy 7. Worst pain >4/10 (0-10 Visual Analogue Scale) corresponding to the index site
    Who cannot enter the trial 1. Received chemotherapy or radiotherapy in the preceding six weeks that is likely to alter pain at the index site during the duration of the study 2. Planned chemotherapy during the period of the study that is likely to alter pain during the course of the study 3. Psychotic disorders or cognitive impairment 4. Co-existing lung tumours at the time of study entry 5. Pregnant or breastfeeding
    What will happen The symtoms will be measured using validated questionnaires at end of radiotherapy treatment (week 1), at week 5 and week 12 (final study visit)
    Primary aim This research will assess if radiotherapy is beneficial in treating pain in malignant pleural mesothelioma (MPM).
    Secondary Aim 1. To assess whether radiotherapy improves other symptoms (dyspnoea, fatigue, distress) using a number of validated questionnaires 2. Possible biomarkers will be examined and the relationship between inflammation and symptoms explored
    Participant Information Sheet Not available in web format, please use the contact details below to request a patient information sheet
    Website Sorry, not currently available
    Recruitment Status Recruiting
    Nation Scotland
    Location Edinburgh
  • Contact

    -
    Contact for Public Queries Dr Barry Laird Institute of Genetics and Molecular Medicine Edinburgh Cancer Research UK Centre Western General Hospital Crewe Road Edinburgh EH4 2XR United Kingdom +44 (0)131 777 3548 barry.laird@ed.ac.uk
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.